Follow
Aljoharah M Algabbani
Aljoharah M Algabbani
Saudi Food & Drug Authority
Verified email at sfda.gov.sa
Title
Cited by
Cited by
Year
The Prevalence of Cigarette Smoking in Saudi Arabia in 2018
AM Algabbani, R Almubark, N Althumiri, A Alqahtani, N BinDhim
Food and Drug Regulatory Science Journal 1 (1), 1-1, 2018
822018
Treatment adherence among patients with hypertension: findings from a cross-sectional study
FM Algabbani, AM Algabbani
Clinical Hypertension 26 (1), 1-9, 2020
742020
Health literacy in Saudi Arabia: Implications for public health and healthcare access
R Almubark, M Basyouni, A Alghanem, N Althumairi, D Alkhamis, ...
Pharmacology Research & Perspectives 7 (4), e00514, 2019
392019
Waterpipe tobacco chemical content, microbial contamination, and genotoxic effects: a systematic review
RH Aljadani, AM Algabbani, JA Alamir, AS Alqahtani, NF BinDhim
International Journal of Toxicology 39 (3), 256-262, 2020
162020
The National Survey of Health, Diet, Physical Activity and Supplements among Adults in Saudi Arabia
NA Althumiri, NS Alammari, RA Almubark, FA Alnofal, DJ Alkhamis, ...
Food and Drug Regulatory Science Journal 1 (1), 1-1, 2018
162018
Prevalence and determinants of non-communicable diseases in Saudi Arabia
A Algabbani, A Alqahtani, N BinDhim
Food and Drug Regulatory Science Journal 2 (2), 1-1, 2019
152019
Vaccine Hesitancy among Healthcare Providers at the Beginning of a Pandemic: The Case of COVID-19 Vaccines
F Algabbani, O Alomeir, M Alhussayen, A Algabbani
Saudi Journal of Health Systems Research 2 (3), 98-106, 2022
102022
The impact of using pictorial aids in caregivers’ understanding of patient information leaflets of pediatric pain medications: A quasi-experimental study
AM Algabbani, KA Alzahrani, SK Sayed, M Alrasheed, D Sorani, ...
Saudi Pharmaceutical Journal 30 (5), 544-554, 2022
92022
Vaccine hesitancy in the Gulf Cooperation Council countries
A Algabbani, O AlOmeir, F Algabbani
Eastern Mediterranean Health Journal 29 (5), 402-411, 2023
72023
National prevalence, perceptions, and determinants of tobacco consumption in Saudi Arabia
AM Algabbani, NA Althumiri, AM Almarshad, NF BinDhim
Food and Drug Regulatory Science Journal 2 (2), 1-1, 2019
62019
Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clinical Hypertension [revista en Internet] 2020 [acceso 4 de febrero de 2021]; 26 …
F Algabbani, A Algabbani
BMC 1, 1-9, 2020
5*2020
The inadvertent consequences of drug recalls: A case study of a recall of pantoprazole generics from the markets
AM Algabbani, WA Alkeridy, MA Alessa, AA Alrwisan
Saudi Pharmaceutical Journal 31 (7), 1181-1185, 2023
22023
Readability of information imprinted in patient information leaflets (PILs) in Saudi Arabia: The case of antihypertensive medications
AM Algabbani, SA Alzahrani, SM Almomen, RA Hafiz
Exploratory Research in Clinical and Social Pharmacy 8, 100179, 2022
22022
Willingness and determinants of participation in public health research: a cross-sectional study in Saudi Arabia
A Algabbani, A Alqahtani, N BinDhim
Eastern Mediterranean Health Journal 27 (1), 59-66, 2021
22021
Smoking prevalence, nicotine dependence, and intention to quit among cigarettes smokers
A Algabbani, N BinDhim
European Journal of Public Health 30 (Supplement_5), ckaa166. 1177, 2020
22020
Vaccine hesitancy among healthcare providers during COVID-19 pandemic
F Algabbani, A Algabbani
European Journal of Public Health 31 (Supplement_3), ckab164. 101, 2021
12021
Passive smoking and knowledge of its health hazards in the Kingdom of Saudi Arabia
A Algabbani, N Bin Dhim
European Journal of Public Health 30 (Supplement_5), ckaa165. 1362, 2020
12020
Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis
AM Algabbani, AS Alangari
Saudi Pharmaceutical Journal 31 (12), 101841, 2023
2023
Impact of COVID-19 on Health Care Service Provider Practices in Saudi Arabia
O AlOmeir, KY Alahdal, M Alrouji, F Algabbani, A Algabbani, S Alhajlah, ...
Journal of Population Therapeutics and Clinical Pharmacology 30 (5), 238-248, 2023
2023
Pediatric drug safety surveillance in Saudi Arabia: A description of adverse drug reactions from the Saudi vigilance database
M Alrasheed, RI Alolayet, FF Alharbi, AM Algabbani, R Hafiz
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 581-582, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20